# OnCo record anetumab-ravtansine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/anetumab-ravtansine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "anetumab-ravtansine" ;
  schema:name "Anetumab ravtansine"@en ;
  schema:alternateName "BAY 94-9343"@en ;
  schema:description "Anetumab ravtansine was the first antibody-drug conjugate tested in a randomised trial in mesothelioma, aimed at the mesothelin protein that nearly all mesotheliomas carry; it was no better than vinorelbine chemotherapy as second-line treatment, and is now being tried with pembrolizumab."@en ;
  schema:url <https://onco.cc/drugs/anetumab-ravtansine/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anetumab_ravtansine> ;
  schema:citation <https://doi.org/10.1016/S1470-2045(22)00061-4>, <https://doi.org/10.1200/JCO.19.02085>, <https://doi.org/10.1158/1535-7163.MCT-13-0926> ;
  onco:status "negative" ;
  onco:tag "gap-fill", "owner-request" ;
  onco:modality "Antibody-drug conjugate (anti-mesothelin antibody, DM4 payload), intravenous" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/pleural-mesothelioma/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/mesothelin/> ;
  onco:drugs <https://onco.cc/drugs/vinorelbine/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:trials <https://onco.cc/trials/anetumab-vs-vinorelbine-mpm/>, <https://onco.cc/trials/nci-anetumab-pembrolizumab-mpm/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-kindler-lancet-oncol/>, <https://onco.cc/key-papers/paper-golfier-mol-cancer-ther/>, <https://onco.cc/key-papers/paper-hassan-j-clin-oncol/> .